APA (7th ed.) Citation

Ruof, J., Klein, G., März, W., Wollschläger, H., Neiss, A., & Wehling, M. (2002). Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: The gap between treatment guidelines and real life treatment patterns. Preventive medicine, 35(1), . https://doi.org/10.1006/pmed.2002.1050

Chicago Style (17th ed.) Citation

Ruof, Jörg, G. Klein, Winfried März, H. Wollschläger, A. Neiss, and Martin Wehling. "Lipid-lowering Medication for Secondary Prevention of Coronary Heart Disease in a German Outpatient Population: The Gap Between Treatment Guidelines and Real Life Treatment Patterns." Preventive Medicine 35, no. 1 (2002). https://doi.org/10.1006/pmed.2002.1050.

MLA (9th ed.) Citation

Ruof, Jörg, et al. "Lipid-lowering Medication for Secondary Prevention of Coronary Heart Disease in a German Outpatient Population: The Gap Between Treatment Guidelines and Real Life Treatment Patterns." Preventive Medicine, vol. 35, no. 1, 2002, https://doi.org/10.1006/pmed.2002.1050.